<div id="readability-page-1">04:06 PM EST, 12/26/2025 (MT Newswires) -- Health care stocks were edging up late Friday afternoon with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each fractionally higher.The iShares Biotechnology ETF (IBB) fell 0.7%.In corporate news, Eli Lilly ( LLY ) will pay a $40 million upfront payment and a $15 million equity investment to ABL Bio, the latter said Friday. The upfront payment is for the license, research, and collaboration agreement for ABL's Grabody platform, ABL said, adding that the two parties are carrying out joint research and development on multiple therapeutic candidates. Eli Lilly ( LLY ) shares rose 0.1%.Johnson &amp; Johnson ( JNJ ) shares were fractionally lower after the company said Friday that a phase 2b trial assessing JNJ-95475939 in moderate to severe atopic dermatitis was terminated early after interim analysis showed that it did not meet the target efficacy.Can-Fite BioPharma ( CANF ) shares jumped 22% after receiving a patent from the Brazilian Patent Office for its A3 adenosine receptor, or A3AR, drugs to treat sexual dysfunction.Aptevo Therapeutics ( APVO ) shares fell 35% after the company said it will implement a 1-for-18 reverse stock split, effective at the start of trading on Tuesday. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

CANF

禮來

醫療保健股票在週五下午小幅上漲。禮來將向 ABL Bio 支付 4000 萬美元的預付款和 1500 萬美元的股權，以達成合作協議。強生的特應性皮炎 2b 期臨牀試驗提前終止。Can-Fite BioPharma 的股票在巴西獲得專利後上漲了 22%。Aptevo Therapeutics 的股票因進行 1 拆 18 的反向股票拆分而下跌了 35%

板塊更新：醫療保健類股在午後小幅上漲